C Trenkwalder Selected Research

C Trenkwalder Research Topics

Disease

15	Parkinson Disease (Parkinson's Disease) 01/2019 - 02/2000
10	Restless Legs Syndrome (Restless Legs) 09/2014 - 05/2001
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 07/2005
4	Dementia (Dementias) 08/2011 - 07/2005
3	Multiple Sclerosis 11/2007 - 02/2000
3	Alzheimer Disease (Alzheimer's Disease) 07/2007 - 07/2005
2	REM Sleep Behavior Disorder 01/2019 - 08/2013
2	Pain (Aches) 01/2018 - 09/2004
2	Sleep Wake Disorders 08/2013 - 06/2001
2	Cognitive Dysfunction 08/2013 - 11/2000
2	Nausea 04/2004 - 05/2001
2	Multiple System Atrophy 02/2001 - 05/2000
1	Drug-Related Side Effects and Adverse Reactions 08/2017
1	Stroke (Strokes) 11/2014
1	Neurologic Manifestations (Neurological Manifestations) 08/2013
1	Weight Loss (Weight Reduction) 08/2009
1	Body Weight (Weight, Body) 08/2009
1	Tauopathies 07/2007
1	Frontotemporal Dementia (Semantic Dementia) 07/2007
1	Synucleinopathies 07/2007
1	Huntington Disease (Huntington's Disease) 10/2006
1	Communicable Diseases (Infectious Diseases) 08/2006
1	Short Bowel Syndrome 03/2005
1	Uremia 09/2004
1	Polyneuropathies (Polyneuropathy) 09/2004
1	Headache (Headaches) 04/2004
1	Fatigue 12/2002
1	Neoplasms (Cancer) 01/2002
1	Prolactinoma (Prolactinomas) 01/2002
1	Neoplasm Metastasis (Metastasis) 01/2002
1	Sleep Apnea Syndromes (Sleep Apnea) 11/2001
1	Sleep Deprivation 07/2001
1	Relapsing-Remitting Multiple Sclerosis 04/2001
1	Parkinsonian Disorders (Parkinsonism) 02/2001
1	Hypersensitivity (Allergy) 02/2001
1	Aphasia (Dysphasia) 11/2000
1	Confusion (Bewilderment) 11/2000
1	Status Epilepticus (Complex Partial Status Epilepticus) 11/2000

Drug/Important Bio-Agent (IBA)

5	Dopamine (Intropin)FDA LinkGeneric 01/2002 - 02/2000
4	Pharmaceutical PreparationsIBA 08/2017 - 05/2000
4	Apomorphine FDA Link 04/2008 - 02/2001
3	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2019 - 02/2000
3	Peptides (Polypeptides)IBA 07/2007 - 11/2006
3	Amyloid beta-PeptidesIBA 07/2007 - 10/2006
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 07/2007
2	Levodopa (L Dopa)FDA LinkGeneric 08/2009 - 10/2001
2	Growth Hormone (Somatotropin)IBA 01/2007 - 02/2001
2	ropinirole (Requip)FDA LinkGeneric 10/2006 - 01/2004
2	Proteins (Proteins, Gene)FDA Link 07/2005 - 01/2002
2	Dopamine Agents (Dopaminergic Agents)IBA 09/2004 - 09/2001
2	Pergolide (Permax)FDA Link 04/2004 - 05/2001
1	SynucleinsIBA 01/2019
1	Analgesics (Analgesic Drugs)IBA 01/2018
1	rotigotine FDA Link 01/2018
1	Opiate AlkaloidsIBA 01/2018
1	Oxycodone (Oxycontin)FDA LinkGeneric 01/2018
1	Matrix Metalloproteinases (MMPs)IBA 11/2014
1	salicylhydroxamic acid (SHAM)IBA 09/2014
1	Interferon-betaIBA 11/2007
1	Hormones (Hormone)IBA 11/2007
1	Interferon beta-1a FDA Link 11/2007
1	CytokinesIBA 11/2007
1	valrubicin (AD 32)FDA Link 07/2007
1	alpha-SynucleinIBA 07/2007
1	Amyloid (Amyloid Fibrils)IBA 10/2006
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2006
1	Biological ProductsIBA 07/2005
1	tau Proteins (tau Protein)IBA 07/2005
1	Threonine (L-Threonine)FDA Link 07/2005
1	S100 Calcium Binding Protein beta SubunitIBA 07/2005
1	IronIBA 09/2004
1	Messenger RNA (mRNA)IBA 01/2002
1	Opioid Analgesics (Opioids)IBA 11/2001
1	benzamideIBA 10/2001
1	3- iodo- 2- hydroxy- 6- methoxy- N- ((1- ethyl- 2- pyrrolidinyl)methyl)benzamideIBA 10/2001
1	Domperidone (Domperidon)IBA 05/2001
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2001
1	Moclobemide (Arima)IBA 04/2001
1	Steroid Receptors (Steroid Receptor)IBA 04/2001
1	Dopamine Receptors (Dopamine Receptor)IBA 02/2001
1	GadoliniumIBA 02/2000

Therapy/Procedure

12	Therapeutics 10/2018 - 06/2001
2	Drug Therapy (Chemotherapy) 08/2017 - 06/2001
2	Deep Brain Stimulation 08/2006 - 04/2001
1	Polypharmacy 08/2017
1	Contraindications 08/2017
1	Nursing Care 08/2011
1	Injections 04/2008
1	Duration of Therapy 11/2007
1	Immunotherapy 12/2002
1	Aftercare (After-Treatment) 11/2000